Vir Biotechnology, Inc. 13F holders
Of the 44 funds followed here, 7 reported a position in Vir Biotechnology, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Point72 Asset Management, 5.7 million shares worth $57.7 million, 0.1% of its reported book.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management | 5,666,821 | $57.7 million | 0.1% | +3,714,587 | added | 30 June 2026 | 13F |
| Geode Capital Management | 3,348,366 | $34.1 million | 0.0% | +690,523 | added | 30 June 2026 | 13F |
| FMR LLC | 2,318,294 | $23.6 million | 0.0% | +246,446 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 1,110,227 | $11.3 million | 0.0% | -329,267 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 1,044,637 | $10.6 million | 0.0% | -1,159,239 | trimmed | 30 June 2026 | 13F |
| Renaissance Technologies | 1,016,864 | $10.4 million | 0.0% | +255,500 | added | 30 June 2026 | 13F |
| Millennium Management | 47,993 | $489,049 | 0.0% | -441,367 | trimmed | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 7 August 2026 | 13G | State Street Corporation and 1 other | 10.0 million | 5.9% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 31 July 2026 | 13G/A | Vanguard Portfolio Management and 1 other | 11.6 million | 6.8% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G/A | SB Investment Advisers (UK) Limited and 5 others | 10.9 million | 6.5% | 31 March 2026 | passive, other (13d-1(d)) | EDGAR |
| 29 April 2026 | 13G | Vanguard Portfolio Management and 1 other | 9.3 million | 5.8% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 February 2026 | 13G/A | SB Investment Advisers (UK) Limited and 5 others | 13.1 million | 9.4% | 31 December 2025 | passive, other (13d-1(d)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 31 August 2026 | 36 | $10.83 | SEC |
| 19 August 2026 | 5,093 | $9.49 | SEC |
| 17 August 2026 | 72 | $9.24 | SEC |
| 11 August 2026 | 1,445 | $8.89 | SEC |
| 6 August 2026 | 183 | $9.11 | SEC |
| 4 August 2026 | 12,632 | $8.90 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 12,632 on 4 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to VIR by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.